0

    542678

    CHCL

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Cian Healthcare Limited Share Price Today

    Investment Returns

    Over 1 Month 0.00% Over 3 Months 0.00% Over 6 Months 94.89% Over 1 Year 145.50%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Cian Healthcare Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 23.90
    • P/E Ratio (TTM) -1.14
    • Beta -2.18
    • Book Value / share 8.24
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text

    Cian Healthcare Limited Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 28.30
    Operating Expense 37.07
    Net Profit -21.02
    Net Profit Margin (%) -74.27
    Earnings Per Share (EPS) -8.41
    EBITDA -18.57
    Effective Tax Rate (%) -0.52
    Particulars MAR 2025 (Values in Cr)
    Revenue 30.88
    Operating Expense 38.56
    Net Profit -19.66
    Net Profit Margin (%) -63.66
    Earnings Per Share (EPS) -7.86
    EBITDA -15.02
    Effective Tax Rate (%) 0.10
    Particulars MAR 2024 (Values in Cr)
    Revenue 58.75
    Operating Expense 59.80
    Net Profit 0.39
    Net Profit Margin (%) 0.66
    Earnings Per Share (EPS) 0.16
    EBITDA 8.42
    Effective Tax Rate (%) -3800.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 67.56
    Operating Expense 66.93
    Net Profit 1.08
    Net Profit Margin (%) 1.59
    Earnings Per Share (EPS) 0.43
    EBITDA 9.02
    Effective Tax Rate (%) 10.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 64.10
    Operating Expense 66.88
    Net Profit -2.28
    Net Profit Margin (%) -3.55
    Earnings Per Share (EPS) -0.91
    EBITDA 5.33
    Effective Tax Rate (%) 4.20
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 12.95
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.22
    EBITDA Margin -20.48
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 23.34
    ROE % 1.33
    ROCE % 4.65
    Total Debt to Total Equity 1.01
    EBITDA Margin 18.67
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 23.00
    ROE % 3.41
    ROCE % 6.59
    Total Debt to Total Equity 1.10
    EBITDA Margin 20.00
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 22.19
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.18
    EBITDA Margin 6.19
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 24.92
    ROE % 0.12
    ROCE % 6.61
    Total Debt to Total Equity 1.23
    EBITDA Margin 16.64
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 16.86
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.78
    EBITDA Margin -8.61
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 24.73
    ROE % 0.63
    ROCE % 4.43
    Total Debt to Total Equity 0.68
    EBITDA Margin 14.67
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 24.57
    ROE % 1.77
    ROCE % 5.54
    Total Debt to Total Equity 0.70
    EBITDA Margin 14.25
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 24.14
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.77
    EBITDA Margin 8.49
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 25.62
    ROE % 0.69
    ROCE % 6.51
    Total Debt to Total Equity 0.84
    EBITDA Margin 13.43
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 17.77
    Total Assets 156.05
    Total Liabilities 156.05
    Total Equity 32.35
    Share Outstanding 2
    Price to Book Ratio 0.20
    Return on Assets (%) -16.64
    Return on Capital (%) -29.74
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.19
    Total Assets 161.17
    Total Liabilities 161.17
    Total Equity 58.33
    Share Outstanding 2
    Price to Book Ratio 0.84
    Return on Assets (%) 0.52
    Return on Capital (%) 0.74
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.32
    Total Assets 160.47
    Total Liabilities 160.47
    Total Equity 57.48
    Share Outstanding 2
    Price to Book Ratio 1.14
    Return on Assets (%) 1.26
    Return on Capital (%) 1.72
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.34
    Total Assets 165.93
    Total Liabilities 165.93
    Total Equity 55.45
    Share Outstanding 2
    Price to Book Ratio 0.79
    Return on Assets (%) -3.33
    Return on Capital (%) -4.67
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.32
    Total Assets 157.25
    Total Liabilities 157.25
    Total Equity 58.24
    Share Outstanding 2
    Price to Book Ratio 0.44
    Return on Assets (%) 0.03
    Return on Capital (%) 0.04
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 17.65
    Total Assets 142.67
    Total Liabilities 142.67
    Total Equity 42.15
    Share Outstanding 2
    Price to Book Ratio 0.20
    Return on Assets (%) -13.77
    Return on Capital (%) -23.93
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.72
    Total Assets 142.89
    Total Liabilities 142.89
    Total Equity 61.81
    Share Outstanding 2
    Price to Book Ratio 0.84
    Return on Assets (%) 0.27
    Return on Capital (%) 0.38
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.12
    Total Assets 140.63
    Total Liabilities 140.63
    Total Equity 61.42
    Share Outstanding 2
    Price to Book Ratio 1.14
    Return on Assets (%) 0.76
    Return on Capital (%) 1.03
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.22
    Total Assets 139.78
    Total Liabilities 139.78
    Total Equity 60.34
    Share Outstanding 2
    Price to Book Ratio 0.79
    Return on Assets (%) -1.62
    Return on Capital (%) -2.2
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.20
    Total Assets 134.63
    Total Liabilities 134.63
    Total Equity 59.87
    Share Outstanding 2
    Price to Book Ratio 0.44
    Return on Assets (%) 0.24
    Return on Capital (%) 0.33
    Particulars MAR 2025 (Values in Cr)
    Net Income -25.97
    Cash from Operations 20.75
    Cash from Investing -0.25
    Cash from Financing -3.92
    Net change in Cash 16.57
    Free Cash Flow 20.79
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.84
    Cash from Operations 11.76
    Cash from Investing -1.45
    Cash from Financing -10.44
    Net change in Cash -0.13
    Free Cash Flow 11.92
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.02
    Cash from Operations 4.84
    Cash from Investing 2.55
    Cash from Financing -7.40
    Net change in Cash -0.01
    Free Cash Flow 5.27
    Particulars MAR 2022 (Values in Cr)
    Net Income -5.53
    Cash from Operations 8.57
    Cash from Investing 1.39
    Cash from Financing -10.95
    Net change in Cash -0.98
    Free Cash Flow 25.89
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.05
    Cash from Operations 5.93
    Cash from Investing 2.71
    Cash from Financing -9.77
    Net change in Cash -1.12
    Free Cash Flow 6.49
    Particulars MAR 2025 (Values in Cr)
    Net Income -19.65
    Cash from Operations 20.65
    Cash from Investing -0.26
    Cash from Financing -3.45
    Net change in Cash 16.92
    Free Cash Flow 20.69
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.38
    Cash from Operations 6.94
    Cash from Investing -0.92
    Cash from Financing -6.41
    Net change in Cash -0.39
    Free Cash Flow 7.08
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.07
    Cash from Operations 2.15
    Cash from Investing -1.08
    Cash from Financing -1.16
    Net change in Cash -0.09
    Free Cash Flow 2.39
    Particulars MAR 2022 (Values in Cr)
    Net Income -2.27
    Cash from Operations 5.50
    Cash from Investing -3.84
    Cash from Financing -2.64
    Net change in Cash -0.98
    Free Cash Flow 22.16
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.32
    Cash from Operations 5.46
    Cash from Investing -1.20
    Cash from Financing -5.06
    Net change in Cash -0.80
    Free Cash Flow 5.87
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.10 17.88 2.08 330.29 23.12 45.50
    BLISS GVS PHARMA LTD. 505.05 40.66 4.49 5365.85 118.35 552.90
    CIPLA LTD 1450.00 32.73 3.40 117137.57 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 551.65 25.80 3.99 1623.56 256.40 564.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.10 30.14 5.55 330.29 23.12 45.50
    AMRUTAJAN HEALTH LTD 525.20 23.54 4.10 1518.39 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8091.60 105.74 23.17 20229.00 7630.00 9850.00
    BLISS GVS PHARMA LTD. 505.05 54.66 4.64 5365.85 118.35 552.90

    Cian Healthcare Limited shareholding pattern

    Holding
    5.0%
    95.0%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Cian Healthcare Limited Technicals Summary

    9.55 4.94 redarrow
    red-green-graph indicator
    0 Bearish
    0 Bullish
    • 5 Days 0.00
    • 26 Days 0.00
    • 10 Days 0.00
    • 50 Days 0.00
    • 12 Days 0.00
    • 100 Days 0.00
    • 20 Days 0.00
    • 200 Days 0.00
    9.55 PIVOT
    First Support 9.55 First Resistance 9.55 Second Support 9.55 Second Resistance 9.55 Third Support 9.55 Third Resistance 9.55
    RSI 87.32 ADX 37.35 MACD 0.00 Williams % R 0.00 Commodity Channel Index (CCI) 179.47
    Date 2026-07-14 Week 2000.00 Same Day 2000.00 Month 2000.00
    1 Year -2.18 3 Year 0.41
    Over 1 Month
    0.00% down
    Over 1 Year
    145.50% down
    Over 3 Months
    0.00% down
    Over 3 Years
    -29.66% down
    Over 6 Months
    94.89% down
    Over 5 Years
    -15.29% down

    Cian Healthcare Limited Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Cian Healthcare Ltd?

    Answer Field

    Cian Healthcare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 9.55 as on Jul 14 2026 12:00 AM.

    What is the Market Cap of Cian Healthcare Ltd Share?

    Answer Field

    The market cap of Cian Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 23.90 as on Jul 14 2026 12:00 AM.

    What is the 52 Week High and Low of Cian Healthcare Ltd?

    Answer Field

    The 52 Week High and Low of Cian Healthcare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 9.55 and ₹ 3.11.

    What is 1 year return for Cian Healthcare Ltd?

    Answer Field

    The 1 year returns on the stock has been 145.50%.

    What is the P/E Ratio of Cian Healthcare Ltd Share?

    Answer Field

    As on Jul 14 2026 12:00 AM the price-to-earnings (PE) ratio for Cian Healthcare Ltd share is -1.14.

    What is the PB ratio of Cian Healthcare Ltd Share?

    Answer Field

    As on Jul 14 2026 12:00 AM, the price-to-book (PB) ratio for Cian Healthcare Ltd share is 8.24.

    How to Buy Cian Healthcare Ltd Share?

    Answer Field

    You can trade in Cian Healthcare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Cian Healthcare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Cian Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Cian Healthcare Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |